All In Biotech

Drug Trial Radar · NCT06808932

VK4-116 Phase I Study With Food-Effect

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study With Food-Effect Cohort to Assess the Safety, Tolerability, and Pharmacokinetics of Oral (R) VK4-116 in Healthy Volunteers

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Jul 2027

Study completion Dec 30, 2027

Sponsor

Sponsor type
NIH
Collaborators
Altasciences Company Inc.
First posted
Feb 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This first-in-human, randomized, double-blind, placebo-controlled, single ascending dose (SAD), phase I study is designed to assess the safety, tolerability and pharmacokinetics of VK4-116 in healthy volunteers in fasted and fed state.

Conditions

  • Opioid Dependence
  • Opioid Use Disorder (OUD)

Interventions

  • VK4-116Drug

    D3R antagonist

  • PlaceboDrug

    Each of the four dose groups of n=8 participants will be assigned to active drug or placebo in the ration 6:2.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Treatment-Emergent Adverse Events in Healthy Adult ParticipantsTime frame: 7 days for fasted condition, 11 days for fed condition

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Altasciences Clinical Kansas

    Overland Park, Kansas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.